Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
David S. Ettinger(Johns Hopkins University), Miranda Hughes(National Comprehensive Cancer Network), Wallace Akerley(University of Utah), Gregory A. Otterson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jules Lin(University of Michigan), Joe Y. Chang(The University of Texas MD Anderson Cancer Center), Billy W. Loo(Princess Margaret Cancer Centre), Jessica R. Bauman, Stephen C. Yang(Johns Hopkins University), Rudy P. Lackner(Susan Thompson Buffett Foundation), Tawee Tanvetyanon(Moffitt Cancer Center), Erminia Massarelli(The University of Texas MD Anderson Cancer Center), Tejas Patil(Sidney Kimmel Comprehensive Cancer Center), Fabien Maldonado(Vanderbilt University Medical Center), Ankit Bharat(Northwestern University), Daniel Morgensztern(Barnes-Jewish Hospital), Patricio M. Polanco(Southwestern Medical Center), Travis E. Grotz(Mayo Clinic in Arizona), Trey C. Mullikin(Cancer Institute (WIA)), Aparna Hegde(University of Colorado Cancer Center), Douglas E. Wood(University of Washington), Dara L. Aisner(University of Colorado System), Matthew A. Gubens(University of California, San Francisco), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Michael Lanuti(Massachusetts General Hospital), Alda L. Tam(The University of Texas MD Anderson Cancer Center), Sandip Pravin Patel(University of California San Diego), Scott Gettinger(Yale Cancer Center), Christine M. Lovly(Dana-Farber Cancer Institute), Edwin Yau, Theresa A. Shapiro(Sidney Kimmel Comprehensive Cancer Center), Jonathan W. Riess(University of California Davis Medical Center), Lucian R. Chirieac(Mount Sinai Hospital), Thomas J. Dilling(Moffitt Cancer Center), Jonathan E. Dowell(Southwestern Medical Center), Aditi P. Singh(University of Nevada, Las Vegas), Thomas Ng(University of Tennessee Health Science Center), Gregory A. Durm(Indiana University Melvin and Bren Simon Comprehensive Cancer Center), Kristina M. Gregory(National Comprehensive Cancer Network), Débora S. Bruno(University Hospitals Cleveland Medical Center), Jane Yanagawa(University of California, Los Angeles), James Stevenson(Cleveland Clinic), Malcolm M. DeCamp(University of Wisconsin Carbone Cancer Center)
Cited by 29
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k